- Home
- ZDAI vs CRIS Comparison
ZDAI vs CRIS Comparison
Compare ZDAI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- CRIS
- Stock Information
- Founded
- ZDAI 2022
- CRIS 2000
- Country
- ZDAI Hong Kong
- CRIS United States
- Employees
- ZDAI N/A
- CRIS N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZDAI Consumer Discretionary
- CRIS Health Care
- Exchange
- ZDAI Nasdaq
- CRIS Nasdaq
- Market Cap
- ZDAI 14.8M
- CRIS 15.9M
- IPO Year
- ZDAI 2024
- CRIS 2000
- Fundamental
- Price
- ZDAI $0.39
- CRIS $1.23
- Analyst Decision
- ZDAI
- CRIS Strong Buy
- Analyst Count
- ZDAI 0
- CRIS 2
- Target Price
- ZDAI N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ZDAI 2.3M
- CRIS 89.5K
- Earning Date
- ZDAI 12-02-2025
- CRIS 11-06-2025
- Dividend Yield
- ZDAI N/A
- CRIS N/A
- EPS Growth
- ZDAI N/A
- CRIS N/A
- EPS
- ZDAI N/A
- CRIS N/A
- Revenue
- ZDAI $19,275,673.00
- CRIS $11,650,000.00
- Revenue This Year
- ZDAI N/A
- CRIS $2.72
- Revenue Next Year
- ZDAI N/A
- CRIS $8.27
- P/E Ratio
- ZDAI N/A
- CRIS N/A
- Revenue Growth
- ZDAI 43.16
- CRIS 13.56
- 52 Week Low
- ZDAI $0.36
- CRIS $1.02
- 52 Week High
- ZDAI $107.36
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- ZDAI 36.90
- CRIS 35.87
- Support Level
- ZDAI $0.45
- CRIS $1.13
- Resistance Level
- ZDAI $0.40
- CRIS $1.35
- Average True Range (ATR)
- ZDAI 0.04
- CRIS 0.11
- MACD
- ZDAI -0.00
- CRIS -0.01
- Stochastic Oscillator
- ZDAI 18.82
- CRIS 19.57
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.